{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:22:23Z","timestamp":1770556943648,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K12 -DK111011-06 (PI Sarma)"],"award-info":[{"award-number":["K12 -DK111011-06 (PI Sarma)"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Bladder Dysfunct Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Shared decision making (SDM) is integral to clinical decision making for OAB. SDM is a collaborative process that takes patients\u2019 values, preferences, and goals into account when deciding on their treatment options. Decision aids (DAs) can support SDM and patient-reported outcomes (PROs) help to assess the outcomes most important to the patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Twenty-five articles were retrieved and reviewed. Our search for literature about SDM in OAB found that physician recommendation is a key decisional component for patients yet that physicians\u2019 priorities may differ widely from patients\u2019 preferences. We evaluated currently available decision aids for OAB and found that none of the peer reviewed aids are publicly available, though non-peer reviewed, paper-based decision aids are available online. At least 10 PROs are available for OAB, these are regularly used in trials of efficacy and are increasingly being implemented in clinical practice. Finally, artificial intelligence applications such as large language models and machine learning based clinical risk prediction tools are emerging as a new facet to augment SDM, but there are limitations on the quality and the clinical implementation of these tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Decision aids and patient reported outcome measures are integral to the delivery of patient-centered, individualized, shared decision making for OAB. Despite this, few freely available DAs exist and many PROs are available, which makes comparison of outcomes between treatments challenging. Emerging AI technologies may further augment the SDM however require validation prior to clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11884-025-00800-x","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:44:45Z","timestamp":1770468285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared Decision Making, Decision Aids and Patient Reported Outcome Measures for Overactive Bladder Care: A Review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-7045","authenticated-orcid":false,"given":"Roshan","family":"Paudel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0705-9028","authenticated-orcid":false,"given":"Maanasa","family":"Bommineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6977-5280","authenticated-orcid":false,"given":"Giulia M.","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"1","key":"800_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11884-016-0344-9","volume":"11","author":"WS Reynolds","year":"2016","unstructured":"Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11(1):8\u201313. https:\/\/doi.org\/10.1007\/s11884-016-0344-9.","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"8","key":"800_CR2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/nau.25557","volume":"43","author":"CN Brodsky","year":"2024","unstructured":"Brodsky CN, Sitto HM, Wittmann D, et al. There is a lot of shame that comes with this\u201d: a qualitative study of patient experiences of isolation, embarrassment, and stigma associated with overactive bladder. Neurourol Urodyn. 2024;43(8):1817\u201325. https:\/\/doi.org\/10.1002\/nau.25557.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"800_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361\u20137. https:\/\/doi.org\/10.1007\/s11606-012-2077-6.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"800_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.euf.2021.04.013","volume":"8","author":"B Gr\u00fcne","year":"2022","unstructured":"Gr\u00fcne B, Kriegmair MC, Lenhart M, et al. Decision aids for shared decision-making in uro-oncology: a systematic review. Eur Urol Focus. 2022;8(3):851\u201369. https:\/\/doi.org\/10.1016\/j.euf.2021.04.013.","journal-title":"Eur Urol Focus"},{"issue":"4","key":"800_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/nau.24915","volume":"41","author":"R Paudel","year":"2022","unstructured":"Paudel R, Lane GI. Delivering patient-centered care through shared decision making in overactive bladder. Neurourol Urodyn. 2022;41(4):884\u201393. https:\/\/doi.org\/10.1002\/nau.24915.","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 2","key":"800_CR6","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","volume":"10","author":"DL Patrick","year":"2007","unstructured":"Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125\u201337. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00275.x.","journal-title":"Value Health"},{"issue":"14","key":"800_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","volume":"32","author":"G Kotronoulas","year":"2014","unstructured":"Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480\u2013501. https:\/\/doi.org\/10.1200\/JCO.2013.53.5948.","journal-title":"J Clin Oncol"},{"issue":"1","key":"800_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the international continence society. Urology. 2003;61(1):37\u201349. https:\/\/doi.org\/10.1016\/s0090-4295(02)02243-4.","journal-title":"Urology"},{"key":"800_CR9","doi-asserted-by":"publisher","unstructured":"Haylen B, De Ridder D, Freeman R. An international urogynecological association (IUGA)\/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. In: Textbook of Female Urology and Urogynecology, Third Edition. CRC Press; 2010. p. 1090\u2013105. https:\/\/doi.org\/10.3109\/9781439807217-111.","DOI":"10.3109\/9781439807217-111"},{"key":"800_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/nau.70044","author":"GM Ippolito","year":"2025","unstructured":"Ippolito GM, Kenton K, Bradley CS, et al. Symptoms of lower urinary tract dysfunction research network (LURN II) urinary urgency phenotyping study: methods and baseline urinary symptoms by age and sex. Neurourol Urodyn. 2025. https:\/\/doi.org\/10.1002\/nau.70044.","journal-title":"Neurourol Urodyn"},{"key":"800_CR11","unstructured":"Harding CK (Chair), Arlandis MC, B\u00f8 K, Cobussen-Boekhorst H, Costantini E, Groen J, Nambiar AK, Omar MI, Peyronnet B, Ph\u00e9 V, Associates G, Farag F, Karavitakis M, Manso M, Monagas S, Moris L, Nic A an, Riogh E, O\u2019Connor N, Sihra L, Tzelves M, de Heide T, van den Bos ML, van Poelgeest-Pomfret N Schouten, editors. Non-neurogenic Female LUTS. In: EAU Guidelines. Edn. Presented at the EAU Annual Congress, Madrid 2025. EAU Guidelines Office; 2025. Accessed August 17, 2025. https:\/\/uroweb.org\/guidelines\/non-neurogenic-female-luts\/chapter\/citation-information"},{"key":"800_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25532","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. Neurourol Urodyn. 2024. https:\/\/doi.org\/10.1002\/nau.25532.","journal-title":"Neurourol Urodyn"},{"key":"800_CR13","volume-title":"Making Health Care Decisions: The Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship","author":"United States. President\u2019s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research","year":"1982","unstructured":"United States. President\u2019s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Making Health Care Decisions: The Ethical and Legal Implications of Informed Consent in the Patient-Practitioner Relationship. President\u2019s Commission for the Study of; 1982."},{"key":"800_CR14","doi-asserted-by":"publisher","unstructured":"Matlock DD, Jackson LR 2nd, Sandhu A, Scherer LD. Past, present, and future of shared decision-making. Circ Cardiovasc Qual Outcomes. 2024;17(7):e010584. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.124.010584.","DOI":"10.1161\/CIRCOUTCOMES.124.010584"},{"key":"800_CR15","unstructured":"AUA White Paper on Implementation of Shared Decision Making into Urological Practice. Accessed May 31. 2022. https:\/\/www.auanet.org\/guidelines\/guidelines\/shared-decision-making"},{"key":"800_CR16","unstructured":"The SHARE Approach. Accessed December 29. 2022. https:\/\/www.ahrq.gov\/health-literacy\/professional-training\/shared-decision\/index.html"},{"key":"800_CR17","unstructured":"(Data-driven). Shared Decision-making (SDM) in the management of incontinence - Uroweb. Accessed August 17, 2025. https:\/\/uroweb.org\/education-events\/urowebinar-data-driven-shared-decision-making-sdm-in-the-management-of-incontinence"},{"key":"800_CR18","unstructured":"E-course: Comparison of overactive bladder (OAB) treatments and shared decision-making (SDM). Accessed August 17. 2025. https:\/\/uroweb.org\/education-events\/comparison-of-oab-treatments-efficacy-complications-side-effects-shared-decision-making-taking-into-consideration-the-patients-values-and-preferences"},{"key":"800_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25416","author":"HM Sitto","year":"2024","unstructured":"Sitto HM, Brodsky CN, Wittmann D, et al. Patient and physician decision-making dynamics in overactive bladder care: a mixed methods study. Neurourol Urodyn. 2024. https:\/\/doi.org\/10.1002\/nau.25416.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"800_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1185\/03007995.2016.1142959","volume":"32","author":"M Heisen","year":"2016","unstructured":"Heisen M, Baeten SA, Verheggen BG, et al. Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments. Curr Med Res Opin. 2016;32(4):787\u201396. https:\/\/doi.org\/10.1185\/03007995.2016.1142959.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"800_CR21","doi-asserted-by":"publisher","first-page":"300060522109817","DOI":"10.1177\/03000605221098176","volume":"50","author":"SR Kraus","year":"2022","unstructured":"Kraus SR, Li J, Kristy RM, et al. Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the united States. J Int Med Res. 2022;50(5):3000605221098176. https:\/\/doi.org\/10.1177\/03000605221098176.","journal-title":"J Int Med Res"},{"issue":"6","key":"800_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/spv.0000000000000864","volume":"27","author":"KD Khanijow","year":"2021","unstructured":"Khanijow KD, Leri D, Arya LA, Andy UU. A mobile application patient decision aid for treatment of overactive bladder. Female Pelvic Med Reconstr Surg. 2021;27(6):365\u201370. https:\/\/doi.org\/10.1097\/spv.0000000000000864.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"800_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25046","author":"A Kapur","year":"2022","unstructured":"Kapur A, Harandi AA, Cohen T, et al. An analysis of factors that influence patient preference of third-line therapy for overactive bladder. Neurourol Urodyn. 2022. https:\/\/doi.org\/10.1002\/nau.25046.","journal-title":"Neurourol Urodyn"},{"key":"800_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/GME.0000000000001901","volume":"29","author":"F Marques","year":"2021","unstructured":"Marques F, Josloff K, Hung K, Wakamatsu M, Sepucha KR. Decision aids and shared decision making in urogynecology. Menopause. 2021;29:178\u201383. https:\/\/doi.org\/10.1097\/GME.0000000000001901.","journal-title":"Menopause"},{"issue":"3","key":"800_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/nau.24618","volume":"40","author":"S Chhatre","year":"2021","unstructured":"Chhatre S, Newman DK, Wein AJ, Jayadevappa R. Patient preference elicitation instrument, OABCare, to facilitate shared decision-making in the care of overactive bladder. Neurourol Urodyn. 2021;40(3):791\u2013801. https:\/\/doi.org\/10.1002\/nau.24618.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"800_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/nau.25286","volume":"43","author":"L Kessler","year":"2024","unstructured":"Kessler L, Illinsky D, Laudano M, Abraham NE. Do patients experience decisional regret after sacral neuromodulation for refractory overactive bladder? Neurourol Urodyn. 2024;43(1):22\u201330. https:\/\/doi.org\/10.1002\/nau.25286.","journal-title":"Neurourol Urodyn"},{"key":"800_CR27","unstructured":"Lane G. Overactive Bladder Decision Aid. March 1, 2022. Accessed September 22, 2025. https:\/\/med.umich.edu\/1libr\/urology\/OveractiveBladderDecisionAid.pdf"},{"key":"800_CR28","unstructured":"Goessaert AS, van Poelgeest-Pomfret ML, Frigerio M et al. OAB Answers. Published online June 1, 2024. https:\/\/wfipp.org\/app\/uploads\/2024\/11\/Overactive-Bladder-Patient-Decision-Aid.pdf"},{"key":"800_CR29","unstructured":"Care Pathways \u2013 OAB CCP, Accessed. September 22, 2025. https:\/\/sufuorg.com\/resources\/overactive-bladder-ccp.aspx"},{"key":"800_CR30","unstructured":"The OABA. Pilot Study: Evaluating a Digital Intervention for Overactive Bladder."},{"key":"800_CR31","unstructured":"Gill M. RiSolve App for Overactive Bladder \u00b7 Recruiting Participants for Clinical Trial 2025. October 9, 2021. Accessed September 22, 2025. https:\/\/www.withpower.com\/trial\/risolve-app-for-overactive-bladder-55a0e"},{"key":"800_CR32","unstructured":"How It Works. WiserCare Advance Care Planning and Decision Support. Accessed September 22. 2025. https:\/\/www.wisercare.com\/how-it-works-1"},{"issue":"8","key":"800_CR33","doi-asserted-by":"publisher","first-page":"e2424793","DOI":"10.1001\/jamanetworkopen.2024.24793","volume":"7","author":"AK Balitsky","year":"2024","unstructured":"Balitsky AK, Rayner D, Britto J, et al. Patient-reported outcome measures in cancer care: an updated systematic review and Meta-analysis: an updated systematic review and Meta-analysis. JAMA Netw Open. 2024;7(8):e2424793. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.24793.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"800_CR34","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-025-03507-y","volume":"31","author":"E Basch","year":"2025","unstructured":"Basch E, Schrag D, Jansen J, et al. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025;31(4):1225\u201332. https:\/\/doi.org\/10.1038\/s41591-025-03507-y.","journal-title":"Nat Med"},{"issue":"6","key":"800_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/a:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563\u201374. https:\/\/doi.org\/10.1023\/a:1016370925601.","journal-title":"Qual Life Res"},{"issue":"12","key":"800_CR36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","volume":"104","author":"CJ Kelleher","year":"1997","unstructured":"Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. BJOG. 1997;104(12):1374\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.1997.tb11006.x.","journal-title":"BJOG"},{"issue":"6","key":"800_CR37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","volume":"49","author":"KS Coyne","year":"2006","unstructured":"Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006;49(6):1079\u201386. https:\/\/doi.org\/10.1016\/j.eururo.2006.01.007.","journal-title":"Eur Urol"},{"key":"800_CR38","unstructured":"Uebersax JS, Wyman JF, Shumaker SA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress \u2026. Neurourol Urodyn. 1995. https:\/\/doi.org\/10.1002\/nau.1930140206?casa_token=71cI_fk7RyYAAAAA:Fm8pKCknGlyXeDU_wRV3qzA4R1Zh0EMgMTyCaaKdZRXEgOHi1Dlmg1IyaZtXKD3Tjn4zj-IlIaRFnojv. Published online."},{"issue":"6","key":"800_CR39","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/s0022-5347(01)63347-0","volume":"159","author":"SA Shumaker","year":"1998","unstructured":"Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. J Urol. 1998;159(6):2255\u20132255. https:\/\/doi.org\/10.1016\/s0022-5347(01)63347-0.","journal-title":"J Urol"},{"issue":"4","key":"800_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.20041","volume":"23","author":"K Avery","year":"2004","unstructured":"Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322\u201330. https:\/\/doi.org\/10.1002\/nau.20041.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"800_CR41","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/nau.24067","volume":"38","author":"D Cella","year":"2019","unstructured":"Cella D, Smith AR, Griffith JW, et al. A new outcome measure for LUTS: symptoms of lower urinary tract dysfunction research network symptom index-29 (LURN SI-29) questionnaire. Neurourol Urodyn. 2019;38(6):1751\u20139. https:\/\/doi.org\/10.1002\/nau.24067.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"800_CR42","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/nau.22468","volume":"33","author":"AM Suskind","year":"2014","unstructured":"Suskind AM, Dunn RL, Morgan DM, DeLancey JOL, McGuire EJ, Wei JT. The Michigan incontinence symptom index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence. Neurourol Urodyn. 2014;33(7):1128\u201334. https:\/\/doi.org\/10.1002\/nau.22468.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"800_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology. 2006;68(2):318\u201323. https:\/\/doi.org\/10.1016\/j.urology.2006.02.042.","journal-title":"Urology"},{"issue":"6","key":"800_CR44","doi-asserted-by":"publisher","first-page":"e2100137","DOI":"10.1200\/CCI.21.00137","volume":"6","author":"MJ Hassett","year":"2022","unstructured":"Hassett MJ, Cronin C, Tsou TC, et al. ESyM: an electronic health record-integrated patient-reported outcomes-based cancer symptom management program used by six diverse health systems. JCO Clin Cancer Inf. 2022;6(6):e2100137. https:\/\/doi.org\/10.1200\/CCI.21.00137.","journal-title":"JCO Clin Cancer Inf"},{"issue":"1","key":"800_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/1471-2407-14-758","volume":"14","author":"JM Giesinger","year":"2014","unstructured":"Giesinger JM, Wintner LM, Zabernigg A, et al. Assessing quality of life on the day of chemotherapy administration underestimates patients\u2019 true symptom burden. BMC Cancer. 2014;14(1):758. https:\/\/doi.org\/10.1186\/1471-2407-14-758.","journal-title":"BMC Cancer"},{"key":"800_CR46","unstructured":"New virtual treatment program for women with overactive bladder. Accessed September 22. 2025. https:\/\/wexnermedical.osu.edu\/departments\/innovations\/urology\/overactive-bladder"},{"issue":"7","key":"800_CR47","doi-asserted-by":"publisher","first-page":"300060525134755","DOI":"10.1177\/03000605251347556","volume":"53","author":"EN Liang","year":"2025","unstructured":"Liang EN, Pei S, Staibano P, van der Woerd B. Clinical applications of large language models in medicine and surgery: a scoping review. J Int Med Res. 2025;53(7):3000605251347556. https:\/\/doi.org\/10.1177\/03000605251347556.","journal-title":"J Int Med Res"},{"issue":"5","key":"800_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/AOG.0000000000003517","volume":"134","author":"D Sheyn","year":"2019","unstructured":"Sheyn D, Ju M, Zhang S, et al. Development and validation of a machine learning algorithm for predicting response to anticholinergic medications for overactive bladder syndrome. Obstet Gynecol. 2019;134(5):946\u201357. https:\/\/doi.org\/10.1097\/AOG.0000000000003517.","journal-title":"Obstet Gynecol"},{"key":"800_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.urology.2024.08.071","volume":"194","author":"GT Werneburg","year":"2024","unstructured":"Werneburg GT, Werneburg EA, Goldman HB, Slopnick E, Roberts LH, Vasavada SP. External validation demonstrates machine learning models outperform human experts in prediction of objective and patient-reported overactive bladder treatment outcomes. Urology. 2024;194:56\u201363. https:\/\/doi.org\/10.1016\/j.urology.2024.08.071.","journal-title":"Urology"},{"key":"800_CR50","unstructured":"Ghassemi M, Naumann T, Schulam P, Beam AL, Chen IY, Ranganath R. A review of challenges and opportunities in machine learning for health. AMIA Summits Transl Sci Proc. 2020;2020:191\u2013200. Accessed September 22, 2025. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7233077\/"},{"key":"800_CR51","doi-asserted-by":"publisher","unstructured":"Ippolito GM, Reines K, Meeks WD, et al. Perceived vs. actual shared decision-making behavior among urologists: A Convergent, Parallel, Mixed-Methods study of Self-Reported practice. Urology Published Online November. 2023;21. https:\/\/doi.org\/10.1016\/j.urology.2023.10.026.","DOI":"10.1016\/j.urology.2023.10.026"},{"issue":"1","key":"800_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tbench.2023.100105","volume":"3","author":"M Javaid","year":"2023","unstructured":"Javaid M, Haleem A, Singh RP. ChatGPT for healthcare services: an emerging stage for an innovative perspective. BenchCouncil Transactions on Benchmarks, Standards and Evaluations. 2023;3(1):100105. https:\/\/doi.org\/10.1016\/j.tbench.2023.100105.","journal-title":"BenchCouncil Transactions on Benchmarks, Standards and Evaluations"},{"issue":"3","key":"800_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.eururo.2023.03.037","volume":"84","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Wang X, Li X, Liao L. Is ChatGPT an evidence-based doctor? Eur Urol. 2023;84(3):355\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.037.","journal-title":"Eur Urol"},{"issue":"1","key":"800_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41391-023-00705-y","volume":"27","author":"A Cocci","year":"2024","unstructured":"Cocci A, Pezzoli M, Lo Re M, et al. Quality of information and appropriateness of ChatGPT outputs for urology patients. Prostate Cancer Prostatic Dis. 2024;27(1):103\u20138. https:\/\/doi.org\/10.1038\/s41391-023-00705-y.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Current Bladder Dysfunction Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11884-025-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11884-025-00800-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11884-025-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:44:48Z","timestamp":1770468288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11884-025-00800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s11884-025-00800-x","relation":{},"ISSN":["1931-7220"],"issn-type":[{"value":"1931-7220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}